Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prime Medicine Inc (NQ: PRME )

4.800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 4.800
Bid (Size) 4.260 (1)
Ask (Size) 5.140 (2)
Prev. Close 4.800
Today's Range 4.800 - 4.800
52wk Range 4.340 - 17.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
From Prime Medicine, Inc.
Via GlobeNewswire
2 Magnificent Growth Stocks With Room to Run
These deeply undervalued growth stocks could be big winners for patient shareholders. 
Via The Motley Fool

Performance

YTD
-45.21%
-45.21%
1 Month
-30.13%
-30.13%
3 Month
-27.38%
-27.38%
6 Month
-29.93%
-29.93%
1 Year
-63.33%
-63.33%

More News

Read More
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
Via InvestorPlace
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
Via InvestorPlace
Recap: Prime Medicine Q4 Earnings
Via Benzinga
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Announces Pricing of Upsized Public Offering
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Announces Proposed Public Offering of Common Stock
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
From Prime Medicine, Inc.
Via GlobeNewswire
2 gene editing stocks to keep on your 2024 watchlist
Via MarketBeat
Exposures Product Safety
Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
Better Growth Stock: Archer Aviation or Prime Medicine?
Via The Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Via The Motley Fool
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
Via The Motley Fool
Prime Medicine to Present at Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Ryanair Holdings, Prime Medicine And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
DISH Network, Goodyear And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.